ALERE BINAXNOW STREPTOCOCCUS PNEUMONIAE ANTIGEN CARD BN710-012

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2018-07-18 for ALERE BINAXNOW STREPTOCOCCUS PNEUMONIAE ANTIGEN CARD BN710-012 manufactured by Alere Scarborough Inc..

Event Text Entries

[114818687] Testing was performed at alere (b)(4) on retained device lot e03388 associated with kit lot e03885 with the following presumed negative urine samples and positive controls. All test results were valid and performed as expected. Additionally, the manufacturing batch records for lot e03388 were reviewed. This lot met the required release specifications. A review of the complaints reported false negative related to lot number e03388 showed no similar complaints. The evidence available does not indicate that the product is performing outside label claims. Alere (b)(4) was unable to determine the exact root cause of the reported issue. The available evidence suggests that this device lot is performing within labeled claims.
Patient Sequence No: 1, Text Type: N, H10


[114818688] The customer reported a faint positive result was obtained with the alere binaxnow streptococcus pneumoniae antigen card test which was repeated and the same result occurred. A second sample was tested with a negative result obtained. Based on the information available, it appears a malfunction may have occurred with the conflicting binaxnow streptococcus pneumoniae antigen card tests. The sample type tested was not reported. In a worst case scenario if cerebral spinal fluid (csf) was used, a false negative result could have occurred. A false negative result may cause a delay in the patient receiving appropriate therapy. As meningitis is a serious, lifethreatening condition delays in treatment may have severe consequences; therefore, this is a reportable event. The patient outcome in this case is unknown. This mdr is a retrospective filing in response to an observation from an fda inspection conducted february 26th to march 2nd , 2018 at alere (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1221359-2018-00471
MDR Report Key7699635
Report SourceHEALTH PROFESSIONAL
Date Received2018-07-18
Date of Report2018-07-18
Date of Event2016-05-05
Date Mfgr Received2018-06-20
Device Manufacturer Date2015-04-23
Date Added to Maude2018-07-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactBENJAMIN CRYSTAL
Manufacturer Street10 SOUTHGATE ROAD
Manufacturer CitySCARBOROUGH ME 04074
Manufacturer CountryUS
Manufacturer Postal04074
Manufacturer Phone2077305820
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameALERE BINAXNOW STREPTOCOCCUS PNEUMONIAE ANTIGEN CARD
Generic NameANTISERA, ALL GROUPS, STREPTOCOCCUS SPP
Product CodeGTZ
Date Received2018-07-18
Catalog NumberBN710-012
Lot NumberE03885
Device Expiration Date2017-02-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerALERE SCARBOROUGH INC.
Manufacturer Address10 SOUTHGATE ROAD SCARBOROUGH ME 04074 US 04074


Patients

Patient NumberTreatmentOutcomeDate
10 2018-07-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.